share_log

Benchmark Maintains Buy on BlueLinx Hldgs, Raises Price Target to $105

Benzinga ·  Feb 23, 2023 09:57

Benchmark analyst Reuben Garner maintains BlueLinx Hldgs (NYSE:BXC) with a Buy and raises the price target from $95 to $105.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment